COVID-19 | WHO chief thanks Health Minister Mandaviya for announcing resumption of vaccine shipments

India would resume the export of COVID-19 vaccines under ‘Vaccine Maitri’ in order to fulfill the commitment towards COVAX

September 22, 2021 10:46 am | Updated 10:46 am IST - New Delhi

An employee works inside a laboratory at the Serum Institute of India (SII), in Pune. File

An employee works inside a laboratory at the Serum Institute of India (SII), in Pune. File

World Health Organisation (WHO) chief Tedros Adhanom Ghebreyesus on Wednesday, September 22, 2021, thanked Union Health Minister Mansukh Mandaviya for announcing resumption of COVID-19 vaccine shipments to the COVAX global pool in October.

COVAX is an initiative for equitable global access to COVID-19 vaccines.

"Thank you Health Minister @mansukhmandviya for announcing #India will resume crucial #COVID19 vaccine shipments to #COVAX in October. This is an important development in support of reaching the 40% vaccination target in all countries by the end of the year. #VaccinEquity," Mr. Ghebreyesus said in a tweet.

Mr. Mandaviya on September 20, announced thatIndia will resume export of surplus COVID-19 vaccines in the fourth quarter of 2021 under the 'Vaccine Maitri' programme and to meet its commitment to the COVAX global pool, but vaccinating its own citizens remains the topmost priority of the government.

Talking about the expected production and supply trends in the coming months, the Minister said the government will receive over 30 crore doses of COVID-19 vaccines in October and over 100 crore doses in the coming quarter from October-December. The cumulative doses administered so far across the country has crossed 82.65crore.

Asserting that vaccination of its citizens remains the government's topmost priority, Mandaviya had said, "India will be resuming export of COVID-19 vaccines under Vaccine Maitri in order to fulfil the commitment of India towards COVAX in line with our motto of 'Vasudhaiva Kutumbakam'." The surplus supply of vaccines will be used to fulfil India's commitment towards the world for the collective fight against COVID-19, he said.

COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and the WHO.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.